Business Context and Reporting Period
This Form 8-K is filed by Derycz Scientific, Inc. (not Research Solutions, Inc.) on December 23, 2009, reporting an event that occurred on December 22, 2009. The company is incorporated in Nevada and maintains its principal executive offices in Santa Monica, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding equity instruments rather than financial performance results.
Material Changes
The company amended common stock purchase warrants originally issued in a private placement on December 22, 2006. The amendment extends the expiration date of these warrants by one year.
- Investor Warrants: 2,250,000 shares at an exercise price of $1.25 per share.
- Placement Agent Warrants: 200,000 shares at an exercise price of $1.25 per share.
- New Expiration Date: December 22, 2010.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the entry into a material definitive agreement (the warrant amendment).
Investor Verification Checklist
- Verify the total number of outstanding warrants (2,450,000) and the potential dilution upon exercise at $1.25 per share.
- Confirm the current market price of the common stock relative to the $1.25 exercise price to assess the likelihood of exercise.
- Review the original Form SB-2 filed on December 28, 2007, for the full terms of the warrants referenced in this amendment.
- Check subsequent filings to determine if the warrants were exercised or expired on the new date of December 22, 2010.